These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6887543)

  • 1. [Clinical study on chemotherapy for multiple myeloma. Part II: Prognostic factors of treatment with prednisolone and sequential melphalan and ifosfamide: MIP therapy].
    Sezaki T; Ishii H; Adachi T; Takahashi I; Ohnoshi T; Kimura I
    Rinsho Ketsueki; 1983 Apr; 24(4):433-9. PubMed ID: 6887543
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical study on the chemotherapy of multiple myeloma. 1. Therapeutic effect of sequential combination therapy using melphalan, ifosfamide, and prednisolone].
    Sezaki T; Ishii H; Osada T; Adachi T; Takahashi I; Ohnoshi T; Kimura I
    Rinsho Ketsueki; 1982 Jun; 23(6):847-53. PubMed ID: 7176091
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic factors in multiple myeloma treated with prednisolone and sequential melphalan and ifosfamide: MIP combination chemotherapy.
    Adachi T; Asano K; Sezaki T; Takahashi I; Kimura I
    Acta Med Okayama; 1982 Feb; 36(1):39-47. PubMed ID: 7064732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study on chemotherapy for multiple myeloma. Part III: The disappearance of M-protein in multiple myeloma].
    Adachi T; Hasegawa M; Asano K; Sezaki T; Ishii H; Takahashi I; Kimura I
    Rinsho Ketsueki; 1983 Apr; 24(4):440-7. PubMed ID: 6887544
    [No Abstract]   [Full Text] [Related]  

  • 5. [Assessment of a nitrosurea combined with cyclophosphamide and prednisone versus melphalan and prednisone in the treatment of multiple myeloma (author's transl)].
    Bezares R; Bomchil G; Saslavsky J; Pavlovsky S; Curutchet M; Quiroga Micheo E; Macchi A; Musso A; Suárez A; Pizzolato M
    Sangre (Barc); 1979; 24(3):241-51. PubMed ID: 472966
    [No Abstract]   [Full Text] [Related]  

  • 6. "Protracted pulse" chemotherapy for refractory myeloma: a preliminary report.
    Manoharan A
    Eur J Haematol; 1990 Nov; 45(5):274-5. PubMed ID: 2261956
    [No Abstract]   [Full Text] [Related]  

  • 7. Combination chemotherapy for multiple myeloma with melphalan, ifosfamide, prednisolone, nitrosourea and vincristine.
    Ishii H
    Acta Med Okayama; 1988 Jun; 42(3):175-82. PubMed ID: 3165236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative studies of intermittent melphalan and prednisolone (MP) versus 5-drug regimen (QUVMP) and 3-drug regimen (QUP) in multiple myeloma].
    Hoshino S; Saito H; Wada M; Akutsu M; Shiozaki H; Takanashi M; Takei Y; Tanaka S; Teramura M; Takada K
    Rinsho Ketsueki; 1987 Mar; 28(3):358-65. PubMed ID: 3475485
    [No Abstract]   [Full Text] [Related]  

  • 9. [Combination chemotherapy with melphalan, cyclophosphamide, vincristine, ACNU and prednisolone (MEV(Ac)P) for multiple myeloma].
    Takagi T; Oguro M; Sakai C
    Rinsho Ketsueki; 1986 Dec; 27(12):2249-53. PubMed ID: 3471977
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical study on chemotherapy for multiple myeloma: Part IV: Prognostic factors related to long survival].
    Adachi T; Sezaki T; Hoshijima T; Izumi K; Tsubota T; Asano K; Takahashi I; Kimura I; Murakami M
    Rinsho Ketsueki; 1988 Apr; 29(4):494-501. PubMed ID: 3165478
    [No Abstract]   [Full Text] [Related]  

  • 11. Effectiveness of two-stage treatment of multiple myeloma with melphalan and with melphalan in combination with cyclophosphamide, carmustine, vincristine and prednisone.
    Snigurowicz J; Kraj M; Rostkowska J; Maj S; Mariańska B; Mendek E; Roszkowski S; Kilian Z; Kołakowski L
    Arch Immunol Ther Exp (Warsz); 1981; 29(2):145-53. PubMed ID: 7030265
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience of K18 (IgG-melphalan) for five cases of refractory multiple myeloma.
    Kanamaru R; Wakui A; Ishioka C; Okuno M; Konishi Y; Ishikawa A; Shibata H
    Sci Rep Res Inst Tohoku Univ Med; 1988 Dec; 35(1-4):35-40. PubMed ID: 3267125
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase III study of intermittent carmustine (BCNU), cyclophosphamide, and prednisone versus intermittent melphalan and prednisone in myeloma.
    Abramson N; Lurie P; Mietlowski WL; Schilling A; Bennett JM; Horton J
    Cancer Treat Rep; 1982 Jun; 66(6):1273-7. PubMed ID: 7044535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two combination chemotherapy regimens for multiple myeloma: methyl-CCNU, cyclophosphamide, and prednisone versus melphalan and prednisone.
    Cavagnaro F; Lein JM; Pavlovsky S; Becherini JO; Pileggi JE; Micheo EQ; Jait C; Musso A; Suárez A; Pizzolato M
    Cancer Treat Rep; 1980 Jan; 64(1):73-9. PubMed ID: 6991106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy with MCNU, vindesine, melphalan, and prednisolone (MCNU-VMP therapy) in induction therapy for multiple myeloma. Japan Myeloma Study Group.
    Imamura Y; Takagi T; Yawata Y; Nishinarita S; Kosaka M; Mikuni C; Takatsuki K; Sezaki T; Mori M; Tsuchiya J
    Int J Hematol; 1994 Feb; 59(2):113-23. PubMed ID: 8018904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Combination chemotherapy of MCNU, melphalan, procarbazine, and prednisolone (MMPP) in multiple myeloma; disappearance of M-peak on serum electrophoretic pattern].
    Kamiya O; Hoshino A; Ohara K; Nagata K; Ono Y; Saito M; Itou T; Yamamoto K
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 1):863-5. PubMed ID: 2469398
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical efficacy of four-drug combination treatment of adriamycin, vincristine, ifosfamide, and prednisolone for patients with malignant lymphoma, especially relapsed or refractory types (author's transl)].
    Kimura I; Ohnoshi T; Oka A; Nakata Y; Hayashi K; Sato M; Nishihara R; Tanaka T; Sezaki T
    Rinsho Ketsueki; 1980 Jun; 21(6):785-91. PubMed ID: 7463736
    [No Abstract]   [Full Text] [Related]  

  • 18. [A case of multiple myeloma responding very well to the combination of K18 with prednisolone].
    Ishioka C; Kanamaru R; Sato T; Konishi Y; Himori T; Mimata Y; Wakui A
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1164-6. PubMed ID: 2436580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of multiple myeloma: renal function in relation to its prognosis].
    Akashi M; Ohta M; Kitagawa S; Furukawa Y; Takeda K; Muroi K; Komatsu N; Ikeda K; Ohsaka A; Yoshida M
    Rinsho Ketsueki; 1988 Nov; 29(11):1991-7. PubMed ID: 3236408
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Treatment of multiple myeloma by a quadruple chemotherapy regime.
    Azam L; Delamore IW
    Br J Haematol; 1974 Jun; 27(2):362. PubMed ID: 4843684
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.